# Esophageal Squamous Cell studies recruiting: 30 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 30 trials that are observational for Esophageal Squamous Cell Carcinoma that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational Esophageal Squamous Cell Carcinoma studies: 30 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/esophageal-squamous-cell-carcinoma

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 30
- Recruiting or not yet: 30
- Read on: November 19, 2026

## Trials

The 25 newest of 30, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 16, 2026 | NCT07939997 | ctDNA Observational Biomarker Validation Study for Evaluation of Esophageal Squamous Cell Carcinoma | University of Colorado, Denver | Observational | Not yet recruiting | Esophageal Squamous Cell Carcinoma (ESCC) | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07939997) |
| October 5, 2026 | NCT07858630 | Radiotherapy Target Volume Delineation in Locally Advanced Esophageal Cancer in the Immunotherapy Era | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Observational | Recruiting | Esophageal Squamous Cell Carcinoma | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07858630) |
| September 16, 2026 | NCT07822906 | Risk of Esophageal Cancer Returning After Immunotherapy, Chemotherapy, and Surgery | Peking University Cancer Hospital & Institute | Observational | Not yet recruiting | Esophageal Squamous Cell Carcinoma (ESCC) | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07822906) |
| August 21, 2026 | NCT07778056 | Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Immunochemotherapy for Resectable Esophageal Cancer: A Target Trial Emulation Study | Henan Cancer Hospital | Observational | Not yet recruiting | Esophageal Squamous Cell Carcinoma (ESCC) | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07778056) |
| August 18, 2026 | NCT07769658 | Standardized MRI and Structured Reporting for Esophageal Squamous Cell Carcinoma | The First Affiliated Hospital of Zhengzhou University | Observational | Not yet recruiting | Esophageal Squamous Cell Carcinoma | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07769658) |
| July 20, 2026 | NCT07714538 | Breath Research Narrow Validation for Gastrointestinal Cancer Detection | Imperial College London | Observational | Recruiting | Oesophageal Squamous Cell Carcinoma, Oesophageal Adenocarcinoma, Gastric Adenocarcinoma, Pancreatic Ductal... | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07714538) |
| July 13, 2026 | NCT07697898 | TDLN-Guided Lymphadenectomy After Neoadjuvant Immunochemotherapy for ESCC | Tongji Hospital | Observational | Not yet recruiting | Esophageal Squamous Cell Carcinoma (ESCC) | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07697898) |
| July 13, 2026 | NCT07697859 | PD-1 Inhibitors Combined With Local Therapy at Different Timings in Oligometastatic ESCC | Fudan University | Observational | Recruiting | Esophageal Squamous Cell Carcinoma (ESCC) | 354 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07697859) |
| May 7, 2026 | NCT07573397 | A Prospective Study of Tumor-specific Tpex in Negative Lymph Nodes for Predicting Pathological Complete Response to Neoadjuvant PD 1... | Fudan University | Observational | Not yet recruiting | Esophageal Cancer | 88 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07573397) |
| April 16, 2026 | NCT07533357 | Tpex Subsets in Negative Tumor Draining Lymph Nodes for Predicting the Efficacy of PD 1 Inhibitors in Advanced or Recurrent Esophageal... | Fudan University | Observational | Not yet recruiting | Esophageal Cancer | 158 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07533357) |
| March 19, 2026 | NCT07482774 | Tumor Microenvironment Changes After Neoadjuvant Chemo-Immunotherapy in Esophageal Squamous Cell Carcinoma | Nanjing Medical University | Observational | Not yet recruiting | Esophageal Squamous Cell Carcinoma | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07482774) |
| January 20, 2026 | NCT07353541 | Standardized Management of Esophageal Fistula in Esophageal Squamous Cell Carcinoma | Peking University Cancer Hospital & Institute | Observational | Not yet recruiting | Esophageal Squamous Cell Carcinoma (ESCC), Esophageal Fistula | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07353541) |
| January 15, 2026 | NCT07343869 | Multicenter Prospective Cohort on Esophageal Endoscopic Submucosal Dissection | Sponsor not shown (see the record) | Observational | Recruiting | Superficial Esophageal Cancer, Oesophageal Adenocarcinoma, Oesophageal Squamous Cell Carcinoma, Barretts Esophagus With... | 750 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07343869) |
| December 5, 2025 | NCT07266363 | Integrated Cf-miRNA and Exosomal miRNA Signature for Early Detection of Esophageal Squamous Cell Carcinoma | City of Hope Medical Center | Observational | Recruiting | ESCC | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07266363) |
| November 5, 2025 | NCT07224750 | A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer | City of Hope Medical Center | Observational | Recruiting | Hepatocellular Carcinoma (HCC), Cholangiocarcinoma, Pancreatic Ductal Adenocarcinoma (PDAC), Esophageal Squamous Cell... | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07224750) |
| September 3, 2025 | NCT07152535 | Multi-omics Monitoring of Dynamic Evolution in Esophageal Squamous Cell Carcinoma: PKU-ESCC-Monitor | Peking University Cancer Hospital & Institute | Observational | Not yet recruiting | Esophageal Squamous Cell Carcinoma (ESCC) | 255 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07152535) |
| July 28, 2025 | NCT07088354 | Deep Learning Model Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma Following Neoadjuvant Immunochemotherapy | Tongji Hospital | Observational | Recruiting | Esophageal Squamous Cell Carcinoma, Neoadjuvant Immunochemotherapy, Pathological Complete Response, Deep Learning | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07088354) |
| July 23, 2025 | NCT07080437 | An Observational Study on the Safety and Efficacy of Immunotherapy Combined With Concurrent Chemoradiotherapy in Elderly Patients With... | Three Gorges Hospital of Chongqing University | Observational | Recruiting | Esophageal Squamous Cell Carcinoma (ESCC) | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07080437) |
| March 21, 2025 | NCT06889402 | Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant Therapy | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Observational | Not yet recruiting | Esophageal Cancer | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06889402) |
| August 19, 2024 | NCT06561178 | Individualized Tumor-Informed CtDNA Analysis for Monitoring Postoperative Recurrence in ESCC (NEOCRTEC2401) | Sun Yat-Sen University Cancer Center | Observational | Recruiting | Esophageal Squamous Cell Carcinoma | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06561178) |
| July 8, 2024 | NCT06490003 | Predicting Postoperative Chemotherapy Efficacy in Patients With Esophageal Squamous Cell Carcinoma | City of Hope Medical Center | Observational | Recruiting | Esophageal Squamous Cell Carcinoma, Chemotherapy Effect, DNA Methylation | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06490003) |
| May 10, 2024 | NCT06408584 | Short-course Hypofractionated Radiotherapy in Combination With Raltitrexed and Tislelizumab | Anhui Provincial Hospital | Observational | Recruiting | Esophageal Squamous Cell Carcinoma | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06408584) |
| December 13, 2023 | NCT06169163 | Volatile Organic Compounds as Breath Biomarkers in Squamous Oesophageal Neoplasms | Imperial College London | Observational | Recruiting | Oesophageal Squamous Cell Carcinoma, Oesophageal Cancer | 518 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06169163) |
| April 27, 2023 | NCT05833594 | Whole-course Immunonutrition Combined With Chemoradiotherapy±ICIs for Local Advanced Patients With Inoperable Esophageal Squamous Cell... | Anhui Provincial Hospital | Observational | Recruiting | Esophageal Squamous Cell Carcinoma, Chemoradiotherapy, Immunonutrition, Inoperable | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05833594) |
| March 8, 2023 | NCT05759325 | An Exploratory Study of ctDNA-MRD in Predicting the Efficacy of Esophageal Squamous Cell Carcinoma | Guangzhou Institute of Respiratory Disease | Observational | Not yet recruiting | Squamous Cell Carcinoma of Esophagus | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05759325) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| City of Hope Medical Center | 3 |
| Peking University Cancer Hospital & Institute | 3 |
| Fudan University | 3 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2 |
| Imperial College London | 2 |
| Tongji Hospital | 2 |
| Anhui Provincial Hospital | 2 |
| Shanghai Cancer Hospital, China | 1 |
| Guangzhou Institute of Respiratory Disease | 1 |
| The First Affiliated Hospital of Zhengzhou University | 1 |
| Nanfang Hospital, Southern Medical University | 1 |
| University of Colorado, Denver | 1 |
| [iOMEDICO AG](https://specstream.ai/data/clinical-trials/company/iomedico-ag) | 1 |
| Three Gorges Hospital of Chongqing University | 1 |
| Nanjing Medical University | 1 |
| Sun Yat-Sen University Cancer Center | 1 |
| Cofactor Genomics, Inc. | 1 |
| Shanghai Zhongshan Hospital | 1 |
| Henan Cancer Hospital | 1 |

## By country

| Country | Trials |
| --- | --- |
| China | 13 |
| United States | 4 |
| United Kingdom | 2 |
| Germany | 1 |
| Japan | 1 |
| France | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Fast food restaurants in the United States](https://specstream.ai/data/businesses/fast-food-restaurants/united-states)
- [B2B medical support companies in the United States](https://specstream.ai/data/businesses/b2b-medical-support-companies/united-states)
- [Retina services clinics in the United States](https://specstream.ai/data/businesses/retina-services-clinics/united-states)
- [Interior design firms in the United States](https://specstream.ai/data/businesses/interior-design-firms/united-states)
- [College counseling companies in the United States](https://specstream.ai/data/businesses/college-counseling-companies/united-states)
- [Ultrasound imaging clinics in the United States](https://specstream.ai/data/businesses/ultrasound-imaging-clinics/united-states)
